Samedi, 16 Février 2019
Dernières nouvelles
Principale » Teva Pharmaceutical Industries Limited (NYSE:TEVA) Reviewed By Analysts

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Reviewed By Analysts

23 Juin 2017

Barrow Hanley Mewhinney & Strauss LLC now owns 32,455,432 shares of the company's stock valued at $1,176,510,000 after buying an additional 5,884,444 shares during the period. The stock has a market capitalization of $32.82 billion, a P/E ratio of 414.167 and a beta of 0.49. The stock decreased 1.02% or $0.32 during the last trading session, reaching $31.05. Another trade for 3,000 shares valued at $4.43M was made by BOYD JEFFERY H on Sunday, January 1.

Chao Ku increased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 407.02% based on its latest 2016Q4 regulatory filing with the SEC. The company's stock had a trading volume of 11,002,452 shares. The institutional investor held 170,305 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $6.17 million, down from 179,720 at the end of the previous reported quarter. It has underperformed by 58.40% the S&P500.

More notable recent Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) news were published by: which released: "Is Teva Pharmaceutical Industries Ltd (ADR) Stock a Migraine Buy?" on June 02, 2017, also with their article: "How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover" published on May 31, 2017, published: "Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Nibble on Its Dividend and Wait" on June 05, 2017. More interesting news about Dermira Inc (NASDAQ:DERM) were released by: and their article: "Dermira to Present at Jefferies 2017 Global Healthcare Conference" published on May 30, 2017 as well as's news article titled: "Novo A Buys AnaptysBio Inc, ObsEva SA, Dermira Inc, Sells Vanguard Total Stock ..." with publication date: June 13, 2017.

Investors sentiment increased to 1.48 in Q4 2016. Its up 0.03, from 0.89 in 2016Q3. It turned negative, as 69 investors sold PCLN shares while 331 reduced holdings. 11 funds opened positions while 42 raised stakes. Pier Capital Limited Liability Company holds 115,506 shares. The New Jersey-based Blackrock Inv Mngmt Ltd Liability has invested 0% in IntriCon Corporation (NASDAQ:IIN). Gideon Cap Advsr accumulated 0.17% or 180 shares. The stock of SAGE Therapeutics Inc (NASDAQ:SAGE) earned "Outperform" rating by Raymond James on Tuesday, September 13. Dimensional Fund Advsrs Limited Partnership has 285,576 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,240 shares or 0% of its portfolio. Richard Bernstein Limited Company has invested 0.31% in Priceline Group Inc (NASDAQ:PCLN). Moreover, Samlyn Cap has 0.09% invested in Dermira Inc (NASDAQ:DERM) for 127,000 shares. Manufacturers Life Co The owns 17,164 shares. (NYSEMKT:GSAT). Ubs Oconnor Limited Liability stated it has 0% of its portfolio in Globalstar, Inc.

House Democrat: 'We need new leadership'
During Thursday's press briefing, Pelosi took several questions about her future in the role of minority leader for the Democrats. And usually they go after the most effective leaders, because they want to take us, diminish the opportunity that we have".

Since January 1, 2017, it had 0 insider purchases, and 12 selling transactions for $26.73 million activity. Finnegan Daniel J sold 3,052 shares worth $5.28M. Teva Pharmaceutical Industries Limited now has a consensus rating of Hold and an average target price of $43.56. 10,964 were reported by Professional Advisory. Oppenheimer maintained the shares of TEVA in report on Friday, April 7 with "Buy" rating. They now have a United States dollars 40 price target on the stock.

Barrow Hanley Mewhinney & Strauss Llc, which manages about $91.02B and $65.44 billion US Long portfolio, decreased its stake in Norwegian Cruise Line Holdings (NASDAQ:NCLH) by 261,330 shares to 7.06M shares, valued at $300.06M in 2016Q4, according to the filing. One investment analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and fourteen have assigned a buy rating to the company. Therefore 52% are positive.

TEVA has been the subject of a number of research analyst reports. The firm has "Neutral" rating given on Wednesday, February 22 by H.C. Wainwright. As per Wednesday, May 4, the company rating was initiated by Credit Suisse. The rating was maintained by Mizuho on Tuesday, May 10 with "Buy". The firm has "Buy" rating given on Friday, June 16 by Mizuho.

02/13/2017 - Teva Pharmaceutical Industries Limited had its "hold" rating reiterated by analysts at Maxim Group. The rating was maintained by Morgan Stanley on Tuesday, May 3 with "Overweight". The rating was downgraded by Goldman Sachs to "Neutral" on Friday, July 15. As per Wednesday, July 29, the company rating was maintained by RBC Capital Markets. Vetr cut shares of Teva Pharmaceutical Industries Limited from a "strong-buy" rating to a "buy" rating and set a $37.32 price objective on the a research note on Monday, March 13th.